Are you Dr. Turner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 52 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
# Univ
Rochester, NY 14642Phone+1 585-275-3191Fax+1 585-273-3637- Is this information wrong?
Summary
- Dr. Bradley Turner, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York, Florida, and North Carolina. He is affiliated with Strong Memorial Hospital of the University of Rochester, Highland Hospital, and Canandaigua Veterans Affairs Medical Center.
Education & Training
University at Buffalo (Roswell Park Cancer Institute) Oncologic PathologyFellowship, Selective Pathology, 2010 - 2011
University of FloridaResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Southern Regional Area Health Education Center/Duke University HospitalResidency, Family Medicine, 1997 - 2000
Rutgers Robert Wood Johnson Medical SchoolClass of 1997
Certifications & Licensure
NY State Medical License 2010 - 2025
FL State Medical License 2001 - 2024
NC State Medical License 1998 - 2003- American Board of Family Medicine Family Medicine
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls.Huina Zhang, Brian S Finkelman, Mark G Ettel, Moises J Velez, Bradley M Turner, David G Hicks> ;Histopathology. 2024 Mar 5
- In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistoc...Haley Tyburski, Cansu Karakas, Brian S Finkelman, Bradley M Turner, Huina Zhang, David G Hicks> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2024 Mar 1
- HER2 categorical changes after neoadjuvant chemotherapy: A study of 192 matched breast cancers with the inclusion of HER2-Low category.Cansu Karakas, Haley Tyburski, Bradley M Turner, Anna Weiss, Sajal Medha K Akkipeddi, Ajay Dhakal, Kristin Skinner, David G Hicks, Huina Zhang> ;Human Pathology. 2023 Dec 1
- Join now to see all
Press Mentions
Effects of Source and Level of in Ovo-Injected Vitamin D3 on the Hatchability and Serum 25-Hydroxycholecalciferol Concentrations of Ross 708 BroilersJune 16th, 2020
Hospital Affiliations
Strong Memorial Hospital of the University of RochesterRochester, New York
Highland HospitalRochester, New York
Canandaigua Veterans Affairs Medical CenterCanandaigua, New York
F. F. Thompson HospitalCanandaigua, New York
